NCT04822220

Brief Summary

The purpose of this study is to evaluate the effect of Self-Management Program based on the Individual and Family Self-management Theory on fatigue, daily living activities and well-being of cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 26, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 30, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2022

Completed
Last Updated

January 9, 2024

Status Verified

January 1, 2024

Enrollment Period

1.4 years

First QC Date

March 26, 2021

Last Update Submit

January 6, 2024

Conditions

Keywords

nursingcancer patientsself-managementfatigueactivities of daily livingwell-beingrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in fatigue on the Brief Fatigue Inventory at week 8

    The Brief Fatigue Inventory is a validated, self reported instrument assessing average fatigue.

    Baseline, 2 week, 4 week, 8 week

Secondary Outcomes (2)

  • Change From Baseline in daily living activities on the Katz Index of Independence at week 8

    Baseline, 2 week, 4 week, 8 week

  • Change From Baseline in well-being on Well-Being Questionnaire (22 items) (W-BQ22) at week 8

    Baseline, 2 week, 4 week, 8 week

Study Arms (2)

Experimental

EXPERIMENTAL

Fatigue Self-management Programme

Other: Fatigue Self-management Programme

Controlled

NO INTERVENTION

The control group received routine treatment and nursing care

Interventions

Fatigue Self-management Programme

Experimental

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients for symptom management or supportive care in oncology wards
  • Patients who were at first two days of hospitalization
  • Patients who had score of 3≤ or ≤7 in Fatigue Visual Analogue Scale (VAS)
  • Patients who had score of ≤5 in Pain Analog Visual Scale (VAS)
  • Patients who had score of ≤5 The Modified Borg Scale
  • Patients who had score of 0, 1, 2 or 3 in ECOG Performance scale
  • Patients who had metastases
  • Patients who were over 18 years of age
  • Patients who had orientation of person, place and time
  • Patients who had no communication barriers
  • Patients who agreed to participate in the study

You may not qualify if:

  • Patients who had hospitalized for the purpose of receiving chemotherapy
  • Patients whose Hb value was ≤8 g / dl
  • Patients whose body temperature ≥ 38.5 ° C within the last 24 hours
  • Patients who had diarrhea in the last 24 hours (frequency of defecation ≥ 3 / day)
  • Patients who had a score of ≤ 16 kg / m2 in Body Mass Index (BMI)
  • Patients who had advanced heart failure
  • Patients who had untreated hypothyroidism
  • Patients who diagnosed with major depression and / or treated for depression
  • Patients who had no family member involved in their care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zeynep Karakuş

Antalya, 07058, Turkey (Türkiye)

Location

Related Publications (1)

  • Karakus Z, Ozer Z. The effect of a fatigue self-management program based on individual and family self-management theory in cancer patients: A single-blinded randomized controlled trial. Eur J Oncol Nurs. 2024 Apr;69:102483. doi: 10.1016/j.ejon.2023.102483. Epub 2023 Dec 11.

MeSH Terms

Conditions

NeoplasmsFatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Zeynep Özer

    Akdeniz University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a randomized controlled trial consisting of two groups: experimental and control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

March 26, 2021

First Posted

March 30, 2021

Study Start

November 15, 2020

Primary Completion

April 20, 2022

Study Completion

April 20, 2022

Last Updated

January 9, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP

Locations